-
For the last 15 years, emerging evidence has encouraged clinicians who prescribe hormonal contraception to quick start patients on their chosen contraceptive method on the day of the visit, instead of waiting until after menses begins.
-
About 1.7 million women of childbearing age are prescribed Food and Drug Administration Category D or Category X medications each year. However, despite label warnings, about 6% of U.S. pregnancies occur in women taking medications with known teratogenic risk.
-
A new report emphasizes the need to energize efforts to reach the potential of human papillomavirus (HPV) vaccines to save lives and prevent millions of avoidable cancers and HPV-related conditions in men and women.
-
Bayer HealthCare Pharmaceuticals has received Food and Drug Administration approval for a new inserter for its Mirena intrauterine contraceptive.
-
New chlamydia prevalence estimates confirm that young women particularly young African American women continue to bear a disproportionate burden of disease in the United States.
-
Results from the 2013 National Youth Risk Behavior Survey indicate that among high school students who are sexually active, condom use has declined from 63% in 2003 to 59% in 2013. This decline follows a period of increased condom use throughout the 1990s and early 2000s.
-
Its estimated that 859 out of 100,000 women of reproductive age receive a cancer diagnosis each year in the United States. Up to 80% of all women diagnosed with cancer prior to age 50 survive at least five years.
-
A new campaign, Start Talking. Stop HIV, developed by the Centers for Disease Control and Prevention encourages gay and bisexual men to talk openly with their sexual partners about HIV risk and prevention strategies.
-
Reproductive health advocates are moving quickly following the June 30 Supreme Court ruling that closely held corporations that assert a religious objection do not have to cover contraceptive services and methods in their employer-sponsored health plans as required under the Affordable Care Act.
-
Get up to speed on the latest testing and treatment modalities on the hepatitis C virus (HCV) by watching the archived webcast of the Centers for Disease Control and Preventions (CDCs) Public Health Grand Rounds: The 25th anniversary of the discovery of the hepatitis C virus: looking back to look forward.
